Recurring brain tumor growth is halted with new drug
- Details
- Category: Research
But now Northwestern Medicine scientists, in an international collaboration with scientists at the University of California, San Francisco and the University of Hong Kong, have identified a drug that inhibits growth of the most aggressive meningiomas and how to most accurately identify which meningiomas will respond to the drug.
Investigational COVID mucosal vaccine protects against disease and transmission
- Details
- Category: Research
The study, led by Duke researcher Stephanie N. Langel, Ph.D., demonstrated the potential of a COVID vaccine that works through the mucosal tissue to neutralize the SARS-CoV-2 virus, limiting infections and the spread of active virus in airborne particles.
Using AI to analyze large amounts of biological data
- Details
- Category: Research
Cognitive impairment from severe COVID-19 equivalent to 20 years of ageing, study finds
- Details
- Category: Research
The findings, published in the journal eClinicalMedicine, emerge from the NIHR COVID-19 BioResource.
Findings open way for personalised MS treatment
- Details
- Category: Research
A smarter way to develop new drugs
- Details
- Category: Research
Asthma drug can block crucial SARS-CoV-2 protein
- Details
- Category: Research
Approved by the US Food and Drug Administration (FDA), the drug, called montelukast, has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay fever and hives.
More Pharma News ...
- A new toolkit to engineer safe and efficient therapeutic cells
- About 30% of COVID patients develop "Long COVID," UCLA research finds
- COVID-19 vaccine protects kids and teens from severe illness
- Tumors change their metabolism to spread more effectively
- Study tracks COVID-19 antibodies over time
- New COVID-19 nasal spray outperforms current antibody treatments in mice
- New approach for delivery of anti-HIV antibody therapy shows promise in phase I clinical trial